Can personality traits, obesity, depression, anxiety, and quality of life explain the association between migraine and disordered eating attitudes?

Conclusion: The association of migraine and disordered eating attitudes was shown to be related to depression, anxiety, quality of life and personality traits and may also indicate a more clinically severe migraine. To the best of our knowledge, there is no literature study that deals with all these relevant data together. However, neuropsychiatry-based biological studies are required to better understand this multifaceted association.RESUMO Introdu ção: Poucos estudos exploraram a coexistência de migrânea e hábitos alimentares inadequados. Além disso, os mecanismos fisiopatológicos subjacentes da migrânea e da comorbidade da atitude alimentar inadequada não são claramente entendidos. Objetivo: Este estudo teve como objetivo invest igar a associação entre migrânea e atitudes alimentares inadequadas em relação aos traços de personalidade, obesidade, qualidade de vida, gravidade da migrânea, depressão e ansiedade. Métodos: Este estudo incluiu 91 pacientes com migrânea episódica e 84 indivíduos saudáveis. Questioná rios de autorrelato foram utilizados para avaliar ansiedade, depressão, incapacidade relacionada à enxaqueca, traços de personalidade, qualidade de vida e distúrbios alimentares. Resultados: O Teste de Hábito Alimentar (THA) mostrou hábitos alimentares inadequados em ...
Source: Arquivos de Neuro-Psiquiatria - Category: Neurology Source Type: research

Related Links:

Source: European Journal of Sport Science - Category: Sports Medicine Authors: Source Type: research
Authors: Siamashvili M, Davis S Abstract INTRODUCTION: Bromocriptine mesylate quick release (QR) is a dopamine D2 receptor agonist and is the only oral, primarily centrally acting drug that can be used for the treatment of adults with type 2 diabetes. AREAS COVERED: The authors describe current recommendations on the use of bromocriptine mesylate QR. Major efficacy and safety parameters of the late phase trials, including The Cycloset Safety Trial, have been identified and presented. EXPERT OPINION: Efficacy of bromocriptine mesylate QR monotherapy appears to be low but is compensated by favorable safety pr...
Source: Expert Opinion on Pharmacotherapy - Category: Drugs & Pharmacology Tags: Expert Opin Pharmacother Source Type: research
Acceptance of trauma can also help to reduce its damaging effects. → Support PsyBlog for just $5 per month. Enables access to articles marked (M) and removes ads. → Explore PsyBlog's ebooks, all written by Dr Jeremy Dean: Accept Yourself: How to feel a profound sense of warmth and self-compassion The Anxiety Plan: 42 Strategies For Worry, Phobias, OCD and Panic Spark: 17 Steps That Will Boost Your Motivation For Anything Activate: How To Find Joy Again By Changing What You Do
Source: PsyBlog | Psychology Blog - Category: Psychiatry & Psychology Authors: Tags: Sleep subscribers-only Source Type: blogs
Publication date: Available online 9 October 2020Source: Nutrition, Metabolism and Cardiovascular DiseasesAuthor(s): Vanda Craveiro, Elisabete Ramos, Joana Araújo
Source: Nutrition, Metabolism and Cardiovascular Diseases - Category: Nutrition Source Type: research
CONCLUSION: Most people with migraine in the MAST observational study reported all 3 cardinal symptoms of nausea, photophobia, and phonophobia. As in clinical trials, the most common MBS was photophobia. Patient profiles differed among the groups defined by their MBS. PMID: 31837007 [PubMed - as supplied by publisher]
Source: Headache - Category: Neurology Authors: Tags: Headache Source Type: research
Migraine is a frequently disabling neurologic condition which can be complicated by medication overuse headache and comorbid medical disorders, including obesity, anxiety and depression. Although most migraine management takes place in outpatient clinics, inpatient treatment is indicated for migraine refractory to multiple outpatient treatments, with intractable nausea or vomiting, need for detoxification from medication overuse (such as opioids and barbiturates), and significant medical and psychiatric disease. The goals of inpatient treatment include breaking the current cycle of headache pain, reducing the frequency and...
Source: Neurologic Clinics - Category: Neurology Authors: Source Type: research
We describe the effects of LDX (50mg and 70mg) on the Sheehan Disability Scale (SDS; exploratory endpoint) from both studies. Design: The SDS was assessed at baseline, Week 6, and Week 12/early termination. Analyses included mixed-effects models for repeated measures for the examination of SDS total and domain score changes and a generalized estimating equation model to assess dichotomized remission status (remission [total score ?6] versus nonremission [total score>6]). Results: Least squares (95% confidence interval [CI]) mean treatment differences for SDS total score change from baseline at Week 12 were -2.80 (-3.98,...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: Current Issue Drug Development Original Research binge eating disorder disability functionality lisdexamfetamine dimesylate Sheehan Disability Scale Source Type: research
Cytokine levels are associated with debilitating chronic pain conditions that share obesity as a risk factor (e.g. osteoarthritis and migraines), although their mechanistic connections are not clear. Additionally, pro-inflammatory cytokine levels are correlated with anxiety and depression, both common in pediatric chronic pain. We hypothesized that differences in pain and functional disability in youth with co-morbid chronic pain and obesity may be associated with a cytokine imbalance (i.e. increased pro-inflammatory cytokines and decreased anti-inflammatory cytokines).
Source: The Journal of Pain - Category: Materials Science Authors: Source Type: research
Co-morbid conditions frequently occur in pediatric headaches and may significantly affect their management. Co-morbidities that have been associated with pediatric headaches include attention-deficit/hyperactivity disorder, autism, developmental disabilities, depression, anxiety, epilepsy, obesity, infantile colic, atopic disorders, inflammatory bowel disease and irritable bowel syndrome. The goal of this review is to elucidate common comorbidities associated with pediatric headache, thereby empowering child neurologists to identify common triggers and tailor management strategies that address headache and associated comorbidities.
Source: Seminars in Pediatric Neurology - Category: Neurology Authors: Source Type: research
Comorbid conditions frequently occur in pediatric headaches and may significantly affect their management. Comorbidities that have been associated with pediatric headaches include attention-deficit or hyperactivity disorder, autism, developmental disabilities, depression, anxiety, epilepsy, obesity, infantile colic, atopic disorders, inflammatory bowel disease, and irritable bowel syndrome. The goal of this article is to elucidate common comorbidities associated with pediatric headache, thereby empowering child neurologists to identify common triggers and tailor management strategies that address headache and associated comorbidities.
Source: Seminars in Pediatric Neurology - Category: Neurology Authors: Source Type: research
More News: Anxiety | Brain | Depression | Disability | Eating Disorders & Weight Management | Headache | Migraine | Neurology | Obesity | Study